YY/T 1213-2019 PDF English
US$199.00 · In stock · Download in 9 secondsYY/T 1213-2019: Follicle stimulating hormone testing kit Delivery: 9 seconds. True-PDF full-copy in English & invoice will be downloaded + auto-delivered via email. See step-by-step procedureStatus: Valid YY/T 1213: Evolution and historical versions
| Standard ID | Contents [version] | USD | STEP2 | [PDF] delivery | Name of Chinese Standard | Status |
| YY/T 1213-2019 | English | 199 |
Add to Cart
|
3 days
|
Follicle stimulating hormone testing kit
| Valid |
| YY/T 1213-2013 | English | 170 |
Add to Cart
|
0-9 seconds. Auto-delivery
|
Follicle stimulating hormone quantitative labelling immunoassay kit
| Obsolete |
Excerpted PDFs (Download full copy in 9 seconds upon purchase)PDF Preview: YY/T 1213-2019
YY/T 1213-2019: Follicle stimulating hormone testing kit---This is an excerpt. Full copy of true-PDF in English version (including equations, symbols, images, flow-chart, tables, and figures etc.), auto-downloaded/delivered in 9 seconds, can be purchased online: https://www.ChineseStandard.net/PDF.aspx/YYT1213-2019
Follicle stimulating hormone testing kit
ICS 11.100
C44
People's Republic of China Pharmaceutical Industry Standard
Replacing YY/T 1213-2013
Follicle stimulating hormone assay kit
Foliclestimulatinghormonetestingkit
Published on.2019-05-31
2020-06-01 implementation
State Drug Administration issued
Content
Foreword III
1 Scope 1
2 Normative references 1
3 Category 1
4 Requirements 1
5 Test method 2
6 Labels and instruction manual 4
7 Packaging, transportation, storage 4
Reference 5
Foreword
This standard was drafted in accordance with the rules given in GB/T 1.1-2009.
This standard replaces YY/T 1213-2013. In addition to editorial changes, major technical changes compared to YY/T 1213-2013
as follows.
--- Modified the standard name;
--- Added information on the GB/T 29791.2 in vitro diagnostic medical device manufacturer (marked) in the normative reference document
Part 2. Professional in vitro diagnostic reagents, delete GB 9969-1998, YY 0466-2003 and GB/T 21415-
2008/ISO 17511.2003 (see 2);
--- Revised the requirements for detection limits and the corresponding detection methods (see 4.2 and 5.2);
---Modified linear requirements and corresponding detection methods (see 4.3 and 5.3);
--- Revised the accuracy requirements and corresponding detection methods (see 4.4 and 5.4);
--- Removed the precision within the analysis and the precision between the analysis, combined into the intra-assay precision (see 4.5.1);
--- Revised the requirements for specificity (see 4.6);
--- Deleted the measurement value item of the quality control item;
---Modified the label and the instructions for use (see Chapter 6).
--- Increased packaging should comply with the provisions of GB/T 191 (see 7.1).
Please note that some of the contents of this document may involve patents. The issuing organization of this document is not responsible for identifying these patents.
This standard was proposed by the State Drug Administration.
This standard is under the jurisdiction of the National Medical Clinical Laboratory and the In vitro Diagnostic System Standardization Technical Committee (SAC/TC136).
This standard was drafted. China Food and Drug Control Research Institute, Beijing Medical Device Inspection Institute, Roche Diagnostics Products (Shanghai) Co., Ltd.
Division, Siemens Medical Diagnostics Products (Shanghai) Co., Ltd., Abbott Trade (Shanghai) Co., Ltd., Orson Multi Devices Trading (China) Co., Ltd.
Boao Bio Group Co., Ltd.
The main drafters of this standard. Huang Ying, Yu Ting, Qu Shoufang, Sun Nan, Huang Jie, Wang Ruixia, Cai Xiaorong, Ge Yawen, Wang Shaoying, Xiao Wei, Wang Xuefeng,
Wu Xiaojun, Shi Weihong, Guo Jianfu.
This standard replaces YY/T 1213-2013.
Follicle stimulating hormone assay kit
1 Scope
This standard specifies the classification, requirements, test methods, labels and instructions for use of the follicle stimulating hormone assay kit, packaging, transportation,
Storage.
This standard applies to the kit for quantitative determination of follicle stimulating hormone by the double antibody sandwich method, including enzyme labeling, (electro) chemical
An immunoassay kit for labeling methods such as photo-marking, (time-resolved) fluorescent labeling.
This standard does not apply to semi-quantitative determination of follicle stimulating hormone reagents (eg, test strips, etc.) by colloidal gold or other methods;
A variety of follicle stimulating hormone radioimmunoassay or immunoradiometric kits labeled with a radioisotope such as 125I.
2 Normative references
The following documents are indispensable for the application of this document. For dated references, only dated versions apply to this article.
Pieces. For undated references, the latest edition (including all amendments) applies to this document.
GB/T 191 packaging storage and transportation icon
GB/T 29791.2 Information provided by in vitro diagnostic medical device manufacturers (labeling) Part 2. Professional in vitro diagnostic reagents
3 classification
According to different labeling methods, it can be divided into enzyme label, (electro) chemiluminescent label, (time-resolved) fluorescent label, etc.
The same can be divided into microplate type, tube type, magnetic particles, microspheres and plastic beads; can be divided into manual operation methods and instruments according to different operating procedures
Automatic operation method.
4 requirements
4.1 Appearance
Manufacturers should specify appropriate appearance requirements based on the packaging characteristics of their products. Generally, there should be components and traits of each component of the kit; internal and external
Requirements for packaging, labeling, etc.
4.2 Detection limit
Should not be higher than 2.0 IU/L.
4.3 Linear
Within the linear range given by the manufacturer (the lower limit should not be higher than 2.0 IU/L, the upper limit should be no less than 100 IU/L), and the correlation coefficient (r) should not
Below 0.9900.
4.4 Accuracy
Accuracy should meet one of the following requirements.
a) In the linear range specified by the kit, the follicle stimulating hormone national (or international) standard is tested, and the relative deviation of the determination results should be
YY/T 1213-2019
Follicle stimulating hormone testing kit
ICS 11.100
C44
People's Republic of China Pharmaceutical Industry Standard
Replacing YY/T 1213-2013
Follicle stimulating hormone assay kit
Foliclestimulatinghormonetestingkit
Published on.2019-05-31
2020-06-01 implementation
State Drug Administration issued
Content
Foreword III
1 Scope 1
2 Normative references 1
3 Category 1
4 Requirements 1
5 Test method 2
6 Labels and instruction manual 4
7 Packaging, transportation, storage 4
Reference 5
Foreword
This standard was drafted in accordance with the rules given in GB/T 1.1-2009.
This standard replaces YY/T 1213-2013. In addition to editorial changes, major technical changes compared to YY/T 1213-2013
as follows.
--- Modified the standard name;
--- Added information on the GB/T 29791.2 in vitro diagnostic medical device manufacturer (marked) in the normative reference document
Part 2. Professional in vitro diagnostic reagents, delete GB 9969-1998, YY 0466-2003 and GB/T 21415-
2008/ISO 17511.2003 (see 2);
--- Revised the requirements for detection limits and the corresponding detection methods (see 4.2 and 5.2);
---Modified linear requirements and corresponding detection methods (see 4.3 and 5.3);
--- Revised the accuracy requirements and corresponding detection methods (see 4.4 and 5.4);
--- Removed the precision within the analysis and the precision between the analysis, combined into the intra-assay precision (see 4.5.1);
--- Revised the requirements for specificity (see 4.6);
--- Deleted the measurement value item of the quality control item;
---Modified the label and the instructions for use (see Chapter 6).
--- Increased packaging should comply with the provisions of GB/T 191 (see 7.1).
Please note that some of the contents of this document may involve patents. The issuing organization of this document is not responsible for identifying these patents.
This standard was proposed by the State Drug Administration.
This standard is under the jurisdiction of the National Medical Clinical Laboratory and the In vitro Diagnostic System Standardization Technical Committee (SAC/TC136).
This standard was drafted. China Food and Drug Control Research Institute, Beijing Medical Device Inspection Institute, Roche Diagnostics Products (Shanghai) Co., Ltd.
Division, Siemens Medical Diagnostics Products (Shanghai) Co., Ltd., Abbott Trade (Shanghai) Co., Ltd., Orson Multi Devices Trading (China) Co., Ltd.
Boao Bio Group Co., Ltd.
The main drafters of this standard. Huang Ying, Yu Ting, Qu Shoufang, Sun Nan, Huang Jie, Wang Ruixia, Cai Xiaorong, Ge Yawen, Wang Shaoying, Xiao Wei, Wang Xuefeng,
Wu Xiaojun, Shi Weihong, Guo Jianfu.
This standard replaces YY/T 1213-2013.
Follicle stimulating hormone assay kit
1 Scope
This standard specifies the classification, requirements, test methods, labels and instructions for use of the follicle stimulating hormone assay kit, packaging, transportation,
Storage.
This standard applies to the kit for quantitative determination of follicle stimulating hormone by the double antibody sandwich method, including enzyme labeling, (electro) chemical
An immunoassay kit for labeling methods such as photo-marking, (time-resolved) fluorescent labeling.
This standard does not apply to semi-quantitative determination of follicle stimulating hormone reagents (eg, test strips, etc.) by colloidal gold or other methods;
A variety of follicle stimulating hormone radioimmunoassay or immunoradiometric kits labeled with a radioisotope such as 125I.
2 Normative references
The following documents are indispensable for the application of this document. For dated references, only dated versions apply to this article.
Pieces. For undated references, the latest edition (including all amendments) applies to this document.
GB/T 191 packaging storage and transportation icon
GB/T 29791.2 Information provided by in vitro diagnostic medical device manufacturers (labeling) Part 2. Professional in vitro diagnostic reagents
3 classification
According to different labeling methods, it can be divided into enzyme label, (electro) chemiluminescent label, (time-resolved) fluorescent label, etc.
The same can be divided into microplate type, tube type, magnetic particles, microspheres and plastic beads; can be divided into manual operation methods and instruments according to different operating procedures
Automatic operation method.
4 requirements
4.1 Appearance
Manufacturers should specify appropriate appearance requirements based on the packaging characteristics of their products. Generally, there should be components and traits of each component of the kit; internal and external
Requirements for packaging, labeling, etc.
4.2 Detection limit
Should not be higher than 2.0 IU/L.
4.3 Linear
Within the linear range given by the manufacturer (the lower limit should not be higher than 2.0 IU/L, the upper limit should be no less than 100 IU/L), and the correlation coefficient (r) should not
Below 0.9900.
4.4 Accuracy
Accuracy should meet one of the following requirements.
a) In the linear range specified by the kit, the follicle stimulating hormone national (or international) standard is tested, and the relative deviation of the determination results should be
......
Source: Above contents are excerpted from the full-copy PDF -- translated/reviewed by: www.ChineseStandard.net / Wayne Zheng et al.
Tips & Frequently Asked QuestionsQuestion 1: How long will the true-PDF of English version of YY/T 1213-2019 be delivered?Answer: The full copy PDF of English version of YY/T 1213-2019 can be downloaded in 9 seconds, and it will also be emailed to you in 9 seconds (double mechanisms to ensure the delivery reliably), with PDF-invoice. Question 2: Can I share the purchased PDF of YY/T 1213-2019_English with my colleagues?Answer: Yes. The purchased PDF of YY/T 1213-2019_English will be deemed to be sold to your employer/organization who actually paid for it, including your colleagues and your employer's intranet. Question 3: Does the price include tax/VAT?Answer: Yes. Our tax invoice, downloaded/delivered in 9 seconds, includes all tax/VAT and complies with 100+ countries' tax regulations (tax exempted in 100+ countries) -- See Avoidance of Double Taxation Agreements (DTAs): List of DTAs signed between Singapore and 100+ countriesQuestion 4: Do you accept my currency other than USD?Answer: Yes. www.ChineseStandard.us -- YY/T 1213-2019 -- Click this link and select your country/currency to pay, the exact amount in your currency will be printed on the invoice. Full PDF will also be downloaded/emailed in 9 seconds. Question 5: Should I purchase the latest version YY/T 1213-2019?Answer: Yes. Unless special scenarios such as technical constraints or academic study, you should always prioritize to purchase the latest version YY/T 1213-2019 even if the enforcement date is in future. Complying with the latest version means that, by default, it also complies with all the earlier versions, technically. How to buy and download a true PDF of English version of YY/T 1213-2019?A step-by-step guide to download PDF of YY/T 1213-2019_EnglishStep 1: Visit website https://www.ChineseStandard.net (Pay in USD), or https://www.ChineseStandard.us (Pay in any currencies such as Euro, KRW, JPY, AUD).
Step 2: Search keyword "YY/T 1213-2019".
Step 3: Click "Add to Cart". If multiple PDFs are required, repeat steps 2 and 3 to add up to 12 PDFs to cart.
Step 4: Select payment option (Via payment agents Stripe or PayPal).
Step 5: Customize Tax Invoice -- Fill up your email etc.
Step 6: Click "Checkout".
Step 7: Make payment by credit card, PayPal, Google Pay etc. After the payment is completed and in 9 seconds, you will receive 2 emails attached with the purchased PDFs and PDF-invoice, respectively.
Step 8: Optional -- Go to download PDF.
Step 9: Optional -- Click Open/Download PDF to download PDFs and invoice.
See screenshots for above steps: Steps 1~3 Steps 4~6 Step 7 Step 8 Step 9
|